1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)

OBJECTIVE: To determine whether prostate artery embolization (PAE) is a cost-effective alternative to transurethral resection of the prostate (TURP) in the management of benign prostate hyperplasia (BPH) after 1-year follow-up. DESIGN, SETTING AND MAIN OUTCOME MEASURES: A retrospective cost-utility...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Nikisha, Yung, Nathan, Vigneswaran, Ganesh, de Preux, Laure, Maclean, Drew, Harris, Mark, Somani, Bhaskar, Bryant, Timothy, Hacking, Nigel, Modi, Sachin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749306/
https://www.ncbi.nlm.nih.gov/pubmed/35047801
http://dx.doi.org/10.1136/bmjsit-2020-000071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749306/
https://www.ncbi.nlm.nih.gov/pubmed/35047801
http://dx.doi.org/10.1136/bmjsit-2020-000071

Ejemplares similares